NCT03975920

Brief Summary

During mandibular 3rd molar (wisdom tooth) extractions, when a downward force is placed on the patient's jaw, the patient must tense his/her jaw muscles to oppose it. Patients under moderate/deep sedation or general anesthesia cannot tense their muscles to counter this downward force to prevent injury to the jaw including the temporomandibular joint (TMJ). Bite blocks hold the patient's mouth open but do not counter this downward force on the mandible. Currently, oral and maxillofacial surgeons (OMSs) when surgically removing 3rd molars (wisdom teeth) with moderate/deep sedation or general anesthesia have a dental assistant that stands behind the chair and places their hands on both sides of the jaw to support it and oppose the downward force on the patient's jaw during the extractions. It is hard for the dental assistant to maintain support while anticipating the direction and amount of force placed by the OMS on the patient's jaw during the surgical removal. This may explain the finding that almost a quarter of new onset TMD cases in young adults is associated with 3rd molar removal. This study will look at the use of a jaw support device to provide a stable counterforce to downward forces on the jaw, thus preventing jaw hyperextension and injury to the jaw.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

June 25, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2021

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 6, 2022

Completed
Last Updated

June 6, 2022

Status Verified

May 1, 2022

Enrollment Period

1.7 years

First QC Date

May 21, 2019

Results QC Date

January 21, 2022

Last Update Submit

May 10, 2022

Conditions

Keywords

jaw support devicewisdom teethimpactedTemporomandibular Disorders

Outcome Measures

Primary Outcomes (3)

  • Occurrence of Pain at Follow-up With Wide Opening, or Pain in the Temple, Jaw Joint or Jaw Muscles.

    The primary outcome is the self-report of the occurrence of TMD pain post-baseline. All subjects were pain-free at baseline (i.e., pre-surgically) for TMD pain. TMD pain is deemed to have occurred if the subject's self report endorses at 1, 3 or 6 months post-baseline either or both of the following questions: 1. Pain in jaw when opening mouth wide or 2. Pain in temples, jaw joints or jaw muscles.

    1 Month

  • Occurrence of Pain at Follow-up With Wide Opening, or Pain in the Temple, Jaw Joint or Jaw Muscles.

    The primary outcome is the self-report of the occurrence of TMD pain post-baseline. All subjects were pain-free at baseline (i.e., pre-surgically) for TMD pain. TMD pain is deemed to have occurred if the subject's self report endorses at 1, 3 or 6 months post-baseline either or both of the following questions: 1. Pain in jaw when opening mouth wide or 2. Pain in temples, jaw joints or jaw muscles.

    3 Month

  • Occurrence of Pain at Follow-up With Wide Opening, or Pain in the Temple, Jaw Joint or Jaw Muscles.

    The primary outcome is the self-report of the occurrence of TMD pain post-baseline. All subjects were pain-free at baseline (i.e., pre-surgically) for TMD pain. TMD pain is deemed to have occurred if the subject's self report endorses at 1, 3 or 6 months post-baseline either or both of the following questions: 1. Pain in jaw when opening mouth wide or 2. Pain in temples, jaw joints or jaw muscles.

    6 Month

Secondary Outcomes (12)

  • Occurrence of Pain Related TMD at Follow-up Using the TMD Pain Screener Questionnaire.

    1 Month

  • Occurrence of Pain Related TMD at Follow-up Using the TMD Pain Screener Questionnaire.

    3 months

  • Occurrence of Pain Related TMD at Follow-up Using the TMD Pain Screener Questionnaire.

    6 Months

  • Intensity of Pain at Follow-up Using the Characteristic Pain Index (CPI).

    1 Month

  • Intensity of Pain at Follow-up Using the Characteristic Pain Index (CPI).

    3 Months

  • +7 more secondary outcomes

Study Arms (2)

Usual Care (UC)

NO INTERVENTION

The study control is UC, which involves the dental assistant supporting the jaw during the extractions with concurrent use of a bite block.

Experimental Care (EC)

EXPERIMENTAL

The study intervention for EC is use of the Restful Jaw version 2 (RJ2) device, which supports the jaw during the extractions, with concurrent use of a bite block.

Device: The Restful Jaw Device

Interventions

The Restful Jaw Device is used to support the jaw during dental procedures including surgical removal of 3rd molars (wisdom teeth) with sedation. The device is designed to counter the downward forces placed on the mandible by clinicians during dental procedures and prevent jaw hyperextension (opening too wide) while providing a secure, stable jaw position. When 3rd molar teeth are surgically removed with sedation, a dental assistant stands behind the dental chair and supports the patient's jaw with both hands under the patient's jaw. This device replicates the dental assistant in holding the jaw during dental procedures.

Also known as: RJ2
Experimental Care (EC)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18 to 30 years of age at time of enrollment;
  • Willing to provide informed consent to be randomized to either using the device or not when having surgical removal of 3rd molars with moderate/deep sedation or general anesthesia;
  • Requires surgical removal of bilateral mandibular 3rd molars with moderate/deep sedation or general anesthesia; concurrent maxillary 3rd molars removal allowed;
  • American Society of Anesthesiologists (ASA) Physical Status category 1 (normal healthy patient) or Category 2 (patient with mild systemic disease);
  • Available to be contacted for study purposes by e-mail, phone and/or text;
  • Willing to provide contact information for one other person who will know the patient's whereabouts in the event the patient cannot be reached. This contact information must be different from the patient's contact information;
  • Willing to comply with all study procedures and be available for the six month duration of data collection.

You may not qualify if:

  • In the past 3 months, reports the presence of TMD pain in their temples, jaw joints or jaw muscles;
  • Contraindication(s) for moderate/deep sedation or general anesthesia;
  • Any condition or situation the surgeon determines that would prevent the patient from participating in this study;
  • Inability to understand study procedures or provide consent in English;
  • Device does not fit mandible;
  • Supernumerary 3rd molars present.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Metro Dentalcare Specialty Center

Burnsville, Minnesota, 55306, United States

Location

HealthPartners Eden Prairie Clinc

Eden Prairie, Minnesota, 55344, United States

Location

University of Minnesota School of Dentistry

Minneapolis, Minnesota, 55455, United States

Location

HealthPartners Como Clinic

Saint Paul, Minnesota, 55108, United States

Location

Related Publications (23)

  • Friedman JW. The prophylactic extraction of third molars: a public health hazard. Am J Public Health. 2007 Sep;97(9):1554-9. doi: 10.2105/AJPH.2006.100271. Epub 2007 Jul 31.

    PMID: 17666691BACKGROUND
  • Huang GJ, Rue TC. Third-molar extraction as a risk factor for temporomandibular disorder. J Am Dent Assoc. 2006 Nov;137(11):1547-54. doi: 10.14219/jada.archive.2006.0090.

    PMID: 17082281BACKGROUND
  • Huang GJ, Cunha-Cruz J, Rothen M, Spiekerman C, Drangsholt M, Anderson L, Roset GA. A prospective study of clinical outcomes related to third molar removal or retention. Am J Public Health. 2014 Apr;104(4):728-34. doi: 10.2105/AJPH.2013.301649. Epub 2014 Feb 13.

    PMID: 24524521BACKGROUND
  • Huang GJ, Drangsholt MT, Rue TC, Cruikshank DC, Hobson KA. Age and third molar extraction as risk factors for temporomandibular disorder. J Dent Res. 2008 Mar;87(3):283-7. doi: 10.1177/154405910808700313.

    PMID: 18296615BACKGROUND
  • Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD). J Dent Res. 2002 Apr;81(4):284-8. doi: 10.1177/154405910208100412.

    PMID: 12097315BACKGROUND
  • Juhl GI, Jensen TS, Norholt SE, Svensson P. Incidence of symptoms and signs of TMD following third molar surgery: a controlled, prospective study. J Oral Rehabil. 2009 Mar;36(3):199-209. doi: 10.1111/j.1365-2842.2008.01925.x.

    PMID: 19207447BACKGROUND
  • Akhter R, Hassan NM, Ohkubo R, Tsukazaki T, Aida J, Morita M. The relationship between jaw injury, third molar removal, and orthodontic treatment and TMD symptoms in university students in Japan. J Orofac Pain. 2008 Winter;22(1):50-6.

    PMID: 18351034BACKGROUND
  • Velly AM, Gornitsky M, Philippe P. Contributing factors to chronic myofascial pain: a case-control study. Pain. 2003 Aug;104(3):491-499. doi: 10.1016/S0304-3959(03)00074-5.

    PMID: 12927621BACKGROUND
  • Okeson JP. Bell's orofacial pains: The clinical management of orofacial pain, sixth edition. Vol 6. Illinois: Quintessence Publishing; 2005.

    BACKGROUND
  • Pullinger AG, Monteiro AA. History factors associated with symptoms of temporomandibular disorders. J Oral Rehabil. 1988 Mar;15(2):117-24. doi: 10.1111/j.1365-2842.1988.tb00760.x.

    PMID: 3163728BACKGROUND
  • LeResche L, Mancl LA, Drangsholt MT, Huang G, Von Korff M. Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain. 2007 Jun;129(3):269-278. doi: 10.1016/j.pain.2006.10.012. Epub 2006 Nov 28.

    PMID: 17134830BACKGROUND
  • Plesh O, Gansky SA, Curtis DA, Pogrel MA. The relationship between chronic facial pain and a history of trauma and surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jul;88(1):16-21. doi: 10.1016/s1079-2104(99)70187-3.

    PMID: 10442939BACKGROUND
  • Butler JH, Folke LE, Bandt CL. A descriptive survey of signs and symptoms associated with the myofascial pain-dysfunction syndrome. J Am Dent Assoc. 1975 Mar;90(3):635-9. doi: 10.14219/jada.archive.1975.0147.

    PMID: 1054051BACKGROUND
  • Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol. 1985 Dec;60(6):615-23. doi: 10.1016/0030-4220(85)90364-0.

    PMID: 3865133BACKGROUND
  • Sahebi S, Moazami F, Afsa M, Nabavi Zade MR. Effect of lengthy root canal therapy sessions on temporomandibular joint and masticatory muscles. J Dent Res Dent Clin Dent Prospects. 2010 Summer;4(3):95-7. doi: 10.5681/joddd.2010.024. Epub 2010 Sep 16.

    PMID: 22991607BACKGROUND
  • Humphrey SP, Lindroth JE, Carlson CR. Routine dental care in patients with temporomandibular disorders. J Orofac Pain. 2002 Spring;16(2):129-34.

    PMID: 12043519BACKGROUND
  • American Association of Oral and Maxillofacial Surgeons. Parameters of care: Clinical and practice guidelines for oral and maxillofacial surgeons. 2012. Available at http://www.mfch.cz/doc/ParCare2012Complete.pdf

    BACKGROUND
  • Fernandes P, Velly AM, Anderson GC. A randomized controlled clinical trial evaluating the effectiveness of an external mandibular support device during dental care for patients with temporomandibular disorders. Gen Dent. 2013 Sep-Oct;61(6):26-31.

    PMID: 24064159BACKGROUND
  • Zucuskie T. A controlled clinical trial of the usefulness of an external mandibular support device during routine dental care. Minneapolis: University of Minnesota; 1996.

    BACKGROUND
  • Schiffman EL, Look JO, Hodges JS, Swift JQ, Decker KL, Hathaway KM, Templeton RB, Fricton JR. Randomized effectiveness study of four therapeutic strategies for TMJ closed lock. J Dent Res. 2007 Jan;86(1):58-63. doi: 10.1177/154405910708600109.

    PMID: 17189464BACKGROUND
  • Lan KKG, DeMets DL. Design and analysis of group sequential tests based on the type 1 error spending rate function. Biometrika. 1987;74:149- 154.

    BACKGROUND
  • Gonzalez YM, Schiffman E, Gordon SM, Seago B, Truelove EL, Slade G, Ohrbach R. Development of a brief and effective temporomandibular disorder pain screening questionnaire: reliability and validity. J Am Dent Assoc. 2011 Oct;142(10):1183-91. doi: 10.14219/jada.archive.2011.0088.

    PMID: 21965492BACKGROUND
  • Uppgaard R, Nadeau R, Schiffman EL, Stiharu T, Johnson KS, Hodges JS, Velly AM. Occurrence and Predictors of Postoperative Preauricular and Masticatory Muscle Pain Symptoms After Surgical Removal of Third Molars: A Single-Blind Randomized Controlled Trial Comparing Dental Assistants Supporting the Mandible and the Restful Jaw Device. J Oral Maxillofac Surg. 2024 Jan;82(1):6-18. doi: 10.1016/j.joms.2023.09.021. Epub 2023 Oct 5.

MeSH Terms

Conditions

Temporomandibular Joint DisordersTooth, Impacted

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesTooth Diseases

Limitations and Caveats

Limitations include that outcomes were self-reported, and patients were not examined at follow-up. Enrollment was impacted by stopping of patient recruitment at the beginning of the COVID pandemic.

Results Point of Contact

Title
Dr. Eric Schiffman
Organization
The Restful Jaw Company, LLC

Study Officials

  • Eric Schiffman, DDS, MS

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
In this RCT, it is not feasible to blind patients, surgeons, or dental assistants to treatment after the intervention assignments have occurred, so they will not be blinded. It is, however, feasible to mask the sequence of treatment assignments until the moment each assignment is made, and this will be done, as described in Section 5.4.1, above.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: In this two-arm parallel randomized clinical trial (RCT) design, 294 patients undergoing 3rd molar extractions with moderate/deep sedation or general anesthesia will be randomly allocated to Usual Care (UC) or Experimental Care (EC). The study intervention for EC is use of the Restful Jaw version 2 (RJ2) device, which supports the jaw during the extractions, with concurrent use of a bite block. The study control is UC, which involves the dental assistant supporting the jaw during the extractions with concurrent use of a bite block.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2019

First Posted

June 5, 2019

Study Start

June 25, 2019

Primary Completion

February 25, 2021

Study Completion

February 25, 2021

Last Updated

June 6, 2022

Results First Posted

June 6, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

To facilitate the conduct of further analyses with the data we collect, we will create Limited Data Sets from the completed project in a manner consistent with human subject protection and HIPAA privacy regulations.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
6 months after publication of the first paper.
Access Criteria
These resources will be available to the NIDCR or to other approved investigators according to requirements imposed by the governing IRB and legal requirements, including HIPAA and Data Use Agreements.

Locations